C12Y 204/01258
Dolichyl-p-man:man5glcnac2-pp-dolichol alpha-1,3-mannosyltransferase
Official title: Dolichyl-P-Man:Man5GlcNAc2-PP-dolichol alpha-1,3-mannosyltransferase (2.4.1.258)
C12Y204/01258 (Dolichyl-p-man:man5glcnac2-pp-dolichol alpha-1,3-mannosyltransferase) appears on 9 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 12
- Assignees
- 5
- Inventors
- 11
- Latest grant
- 27 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 1 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 1 | 2 |
By publication year.
Recent patents
- Multiple proteases deficient filamentous fungal cells and methods of use thereof27 Apr 2021US 10,988,791 B2Glykos Finland Oy
- Multiple proteases deficient filamentous fungal cells and methods of use thereof28 Jul 2020US 10,724,063 B2Glykos Finland Oy
- Expression of modified glycoproteins and glycopeptides28 Apr 2020US 10,633,454 B2Conagen Inc.
- Multiple protease deficient filamentous fungal cells and methods of use thereof28 Jan 2020US 10,544,440 B2Glykos Finland Oy
- Expression of modified glycoproteins and glycopeptides29 Oct 2019US 10,457,970 B2Conagen Inc.
- Recombinant organisms and methods for producing glycomolecules with high glycan occupancy24 Jun 2021US 2021/0189002 A1Conagen Inc.
- Recombinant organisms and methods for producing glycomolecules with low sulfation25 Mar 2021US 2021/0087540 A1Conagen Inc.
- Multiple Proteases Deficient Filamentous Fungal Cells and Methods of Use Thereof5 Nov 2020US 2020/0347426 A1Glykos Finland Oy
- Multiple Proteases Deficient Filamentous Fungal Cells and Methods of Use Thereof19 Mar 2020US 2020/0087696 A1Glykos Finland Oy
- Multiple Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof10 Oct 2019US 2019/0309338 A1Glykos Finland Oy
Most cited
By later US patents
- Expression of modified glycoproteins and glycopeptides3US 10,457,970 B2Conagen Inc. · 2019
- Enhanced citric acid production in Aspergillus with inactivated asparagine-linked glycosylation protein 3 (Alg3), and/or increased LaeA expression2US 9,023,637 B2Battelle Memorial Institute · 2015
- Expression of modified glycoproteins and glycopeptides1US 10,633,454 B2Conagen Inc. · 2020